PRIA Logo™
TexasHB 378589th Legislature Regular SessionHouse

Relating to labeling requirements for compounded drug products.

Sponsored By: Barbara Gervin-Hawkins

Failed

Health--GeneralOccupational Regulation--Health OccupationsMEDICINE & PRESCRIPTION DRUGSPACKAGING & LABELING REQUIREMENTSPHARMACIES & PHARMACISTSPHARMACY, TEXAS STATE BOARD OF

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Barbara Gervin-Hawkins

    House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Failed to receive affirmative vote in comm.

    4/28/2025House

  2. Committee substitute considered in committee

    4/28/2025House

  3. Considered in public hearing

    4/28/2025House

  4. Left pending in committee

    4/14/2025House

  5. Testimony taken/registration(s) recorded in committee

    4/14/2025House

  6. Considered in public hearing

    4/14/2025House

  7. Scheduled for public hearing on . . .

    4/14/2025House

  8. Referred to Public Health

    3/26/2025House

  9. Read first time

    3/26/2025House

  10. Filed

    3/5/2025House

Bill Text

Related Bills

Back to State Legislation